United States · FDA National Drug Code directory
Letrozole
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63850-0025_7917d6e0-df93-4c10-97c9-3d90b00b7bd4
- Product NDC
- 63850-0025
- Form
- TABLET
- Composition / generic term
- Letrozole
- Labeler
- Natco Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20110603
- Source listing expiry
- 20261231
Source-listed ingredients
- LETROZOLE — 2.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (63850-0025-1) · 63850-0025-1
- 1000 TABLET in 1 BOTTLE (63850-0025-4) · 63850-0025-4
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →